Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: KewlHand who wrote (344)	1/31/2000 3:27:00 AM
From: Jesse Schulman	of 427

Kewl - oops, pushed your evangelization button, sorry. By mentioning I was long, I'd hoped to be spared that lecture. My point was about trading and it still holds. Short term, approval seems to me more likely to bring attention to bear on the bottom line. That's a familiar pattern in these companies. Why should the shorts panic? Screw the merits. I say again, as clearly as possible: traders will be more likely susceptible to arguments about the small size of the FAP market than off-label and future prostate results. So upwards pressure right after approval is far from certain. No upwards pressure, no squeeze. Trav, of course it's about perceptions. Market behavior usually is. itss

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next